The Bronchopulmonary Dysplasia Treatment Market is poised for substantial growth, with a projected CAGR of 4.88% during the forecast period. By 2029, the market is expected to reach a valuation of US$ 484.54 million.
Bronchopulmonary Dysplasia Treatment Market Introduction and Overview:
Bronchopulmonary dysplasia (BPD) is a prevalent chronic respiratory disease primarily affecting...